Advertisement

Regional Decolonization Aids Multidrug-Resistant Organism-Related Outcomes

0

Benefits include lower carriage, infections, hospitalizations, costs, and deaths

Nearly Half of Older Adults Use Online Physician Ratings

0

Online ratings perceived to be very important nearly as often as word-of-mouth recommendations from family and friends

Many Older Adults Still Have Not Received Care Delayed by COVID-19

0

Stark difference seen in rescheduling of missed test, procedure, or operation by vaccination status

Use of Posterior Spinal Fusion Expected to Increase 80 Percent by 2060

0

Estimated rates expected to nearly triple for men, women aged 75 years and older, but remain flat for those younger than 55 years

For relatively healthy older individuals

Daily Low-Dose Aspirin Does Not Cut Dementia Risk in Seniors

0
Risks for dementia, probable Alzheimer disease, MCI not reduced by low-dose aspirin versus placebo
A new report commissioned by the U.S. government contends that most Americans will encounter at least one diagnostic error in their lifetime

IOM: Most U.S. Patients Will Experience Diagnostic Error

0
Panel urges changes to an increasingly complex health care system

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Anticholinergic medications are associated with an increased risk for incident mild cognitive impairment and cognitive decline in older adults

Anticholinergic Meds May Raise Risk for Cognitive Decline

0
Effects significantly worse among individuals with risk factors for Alzheimer disease
For Medicare beneficiaries with mild cognitive impairment or dementia of uncertain etiology

Amyloid PET Linked to Changes in Management for MCI, Dementia

0
Change in management between pre-, post-PET visits for 60.2 and 63.5 percent with MCI, dementia

Recommended Adult Immunization Schedule Updated for 2022

0

Changes include universal vaccination against hepatitis B for all adults aged 19 through 59 years and for at-risk older adults